PLK1 and neoplasm: Given that CIN is a key contributor to tumor heterogeneity,72 and that PLK1 overexpression is known to induce CIN in tumor cells,12,18 we aimed to identify which of the 65 SDL hits we validated selectively impact the survival of PLK1-overexpressing cells at a single-cell resolution.